Latest period
$10.23B
YoY change
-8.2%
5Y CAGR
+4.7%
Peak year (2015)
$20.50B
Latest annual
$9.46B
Free Cash Flow history chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: $9.46B
Free Cash Flow growth chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: -8.2%
Free Cash Flow history table for Gilead Sciences (GILD) from 1990 to 2025
| 2025 | $9.46B | -8.2% | −$849.00M | ||
| 2024 | $10.30B | +38.9% | +$2.88B | ||
| 2023 | $7.42B | -11.1% | −$923.00M | ||
| 2022 | $8.34B | -22.8% | −$2.46B | ||
| 2021 | $10.80B | +43.7% | +$3.29B | ||
| 2020 | $7.52B | -9.6% | −$801.00M | ||
| 2019 | $8.32B | +11.3% | +$843.00M | ||
| 2018 | $7.48B | -33.9% | −$3.83B | ||
| 2017 | $11.31B | -30.6% | −$4.99B | ||
| 2016 | $16.30B | -20.5% | −$4.20B | ||
| 2015 | $20.50B | +67.2% | +$8.24B | ||
| 2014 | $12.26B | +320.6% | +$9.35B | ||
| 2013 | $2.92B | +4.2% | +$117.00M | ||
| 2012 | $2.80B | -20.2% | −$709.11M | ||
| 2011 | $3.51B | +26.5% | +$735.08M | ||
| 2010 | $2.77B | -2.7% | −$77.97M | ||
| 2009 | $2.85B | +40.5% | +$821.62M | ||
| 2008 | $2.03B | +20.3% | +$341.63M | ||
| 2007 | $1.69B | +51.6% | +$573.90M | ||
| 2006 | $1.11B | +69.2% | +$455.16M | ||
| 2005 | $657.69M | +44.0% | +$201.09M | ||
| 2004 | $456.60M | +133.0% | +$260.60M | ||
| 2003 | $196.00M | +245.0% | +$139.19M | ||
| 2002 | $56.81M | -137.1% | +$210.12M | ||
| 2001 | −$153.31M | +184.8% | −$99.49M | ||
| 2000 | −$53.82M | -28.3% | +$21.28M | ||
| 1999 | −$75.10M | +20.5% | −$12.80M | ||
| 1998 | −$62.30M | -8.8% | +$6.00M | ||
| 1997 | −$68.30M | +238.1% | −$48.10M | ||
| 1996 | −$20.20M | -14.4% | +$3.40M | ||
| 1995 | −$23.60M | -24.6% | +$7.70M | ||
| 1994 | −$31.30M | — | — | ||
| 1992 | −$13.30M | +216.7% | −$9.10M | ||
| 1991 | −$4.20M | +55.6% | −$1.50M | ||
| 1990 | −$2.70M | — | — |
- 2025$9.46B-8.2%
- 2024$10.30B+38.9%
- 2023$7.42B-11.1%
- 2022$8.34B-22.8%
- 2021$10.80B+43.7%
- 2020$7.52B-9.6%
- 2019$8.32B+11.3%
- 2018$7.48B-33.9%
- 2017$11.31B-30.6%
- 2016$16.30B-20.5%
- 2015$20.50B+67.2%
- 2014$12.26B+320.6%
- 2013$2.92B+4.2%
- 2012$2.80B-20.2%
- 2011$3.51B+26.5%
- 2010$2.77B-2.7%
- 2009$2.85B+40.5%
- 2008$2.03B+20.3%
- 2007$1.69B+51.6%
- 2006$1.11B+69.2%
- 2005$657.69M+44.0%
- 2004$456.60M+133.0%
- 2003$196.00M+245.0%
- 2002$56.81M-137.1%
- 2001−$153.31M+184.8%
- 2000−$53.82M-28.3%
- 1999−$75.10M+20.5%
- 1998−$62.30M-8.8%
- 1997−$68.30M+238.1%
- 1996−$20.20M-14.4%
- 1995−$23.60M-24.6%
- 1994−$31.30M—
- 1992−$13.30M+216.7%
- 1991−$4.20M+55.6%
- 1990−$2.70M—
Free Cash Flow values are taken from Gilead Sciences's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Gilead Sciences (GILD)
Free Cash Flow for Gilead Sciences (GILD): headline value $10.23B · YoY -8.2%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Gilead Sciences (GILD) free cash flow totalled $9.46B – declined 8.2% year-over-year.
Gilead Sciences free cash flow has grown on net over the period, with a +4.7% compound annual growth rate over 2020–2025 (5 years).
Between 2015 and 2025, Gilead Sciences free cash flow plunged 53.9%, falling from $20.50B to $9.46B.
The record annual free cash flow stands at $20.50B, reached in 2015; the historical low of −$153.31M was recorded in 2001.
Gilead Sciences Free Cash Flow by Year
Gilead Sciences Free Cash Flow 2025: $9.46B
In 2025, Gilead Sciences reported free cash flow of $9.46B, declined 8.2% below 2024.
Gilead Sciences Free Cash Flow 2024: $10.30B
Gilead Sciences free cash flow in 2024 was $10.30B, surged 38.9% from 2023.
Gilead Sciences Free Cash Flow 2023: $7.42B
2023's free cash flow for Gilead Sciences came in at $7.42B, declined 11.1% below 2022.
Gilead Sciences Free Cash Flow 2022: $8.34B
Gilead Sciences posted free cash flow of $8.34B in 2022, declined 22.8% below 2021.
Gilead Sciences Free Cash Flow 2021: $10.80B
Gilead Sciences free cash flow in 2021 was $10.80B.
See more financial history for Gilead Sciences (GILD).
Sector peers by Free Cash Flow
Healthcare peers of Gilead Sciences (GILD), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation